Tiny synthetic particles could help scientists develop vaccines
against immune response diseases such as multiple sclerosis (MS),
research has shown.
The "nanoparticles" trick the immune system into behaving normally.
In tests on mice, they halted a rodent version of relapsing- remitting MS, the most common form of auto-immune disease.
Scientists believe the technology could be applied to a range of immune system disorders, including Type 1 diabetes, food allergies and asthma. MS occurs when the immune system attacks myelin, the fatty insulation that surrounds nerve fibres.
Breaks in the myelin coating prevent nerve messages being transmitted properly, leading to numbness, tingling and paralysis.
Professor Stephen Miller, from Northwestern University in Chicago, said: "This is a highly significant breakthrough in translational immunotherapy,"
The research appears in the journal Nature Biotechnology.
Most Popular Stories
- SEO Traffic Lab Celebrate Wins at Digital Marketing Event 'Internet World 2013' in London
- Social Media Initiatives Should Follow Customers' Lead
- Apple CEO: Offshore Units Not a 'Tax Gimmick'
- U.S. Senate Accuses Apple of Large-scale Tax Avoidance
- UTEP Water Recycling Project Wins Venture Titles
- Marketo Makes a Mint in IPO: Stock Shoots Up More than 50 Percent
- Bieber Booed at Billboard Awards
- Crude Oil Up, Gasoline Down
- Austin Startup Compare Metrics Raises $3.5 Million for Expansion
- Why So Many Top 'Car Guys' Are Actually Women